We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting MC1R in Metastatic Melanoma

News   Nov 28, 2018 | Original story from University of Colorado Cancer Center

 
Targeting MC1R in Metastatic Melanoma
 
 
 

RELATED ARTICLES

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

A DNA "Clock" To Measure Development in Young Children

News

New research describes how the addition of chemical tags to DNA over time could be used to screen for developmental differences and health problems in children.

READ MORE

Platform Developed To Help Find Treatments for Mental Health Illnesses

News

Scientists have created a drug discovery platform focused on finding new medication options for people dealing with mental illnesses.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE